The Cooper Companies, Inc. $COO Shares Purchased by Diversify Wealth Management LLC

Diversify Wealth Management LLC increased its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 65.4% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 37,303 shares of the medical device company’s stock after buying an additional 14,743 shares during the period. Diversify Wealth Management LLC’s holdings in Cooper Companies were worth $2,667,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. Root Financial Partners LLC lifted its holdings in shares of Cooper Companies by 104.5% in the fourth quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock valued at $26,000 after purchasing an additional 162 shares in the last quarter. SJS Investment Consulting Inc. increased its stake in shares of Cooper Companies by 107.5% during the 1st quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company’s stock worth $26,000 after purchasing an additional 187 shares in the last quarter. Bell Investment Advisors Inc increased its stake in shares of Cooper Companies by 106.3% during the 3rd quarter. Bell Investment Advisors Inc now owns 425 shares of the medical device company’s stock worth $29,000 after purchasing an additional 219 shares in the last quarter. CYBER HORNET ETFs LLC acquired a new position in shares of Cooper Companies during the 2nd quarter worth approximately $36,000. Finally, True Wealth Design LLC raised its position in shares of Cooper Companies by 484.8% during the 4th quarter. True Wealth Design LLC now owns 462 shares of the medical device company’s stock worth $38,000 after purchasing an additional 383 shares during the last quarter. 24.39% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of analysts recently commented on COO shares. Mizuho set a $85.00 price objective on Cooper Companies and gave the company an “outperform” rating in a research note on Thursday, June 4th. Stifel Nicolaus cut their target price on shares of Cooper Companies from $95.00 to $85.00 and set a “buy” rating for the company in a research note on Friday, June 5th. JPMorgan Chase & Co. reduced their target price on shares of Cooper Companies from $80.00 to $71.00 and set a “neutral” rating on the stock in a report on Friday, June 5th. The Goldman Sachs Group set a $61.00 price target on shares of Cooper Companies in a research note on Wednesday, May 27th. Finally, BNP Paribas Exane lowered their price target on shares of Cooper Companies from $95.00 to $92.00 and set an “outperform” rating for the company in a report on Monday, June 8th. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, five have assigned a Hold rating and three have given a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $81.85.

Cooper Companies Stock Performance

Shares of COO stock opened at $71.32 on Tuesday. The company has a current ratio of 1.27, a quick ratio of 0.78 and a debt-to-equity ratio of 0.23. The company has a market cap of $13.91 billion, a PE ratio of 60.44, a P/E/G ratio of 1.85 and a beta of 0.84. The company’s fifty day simple moving average is $65.43 and its 200-day simple moving average is $72.84. The Cooper Companies, Inc. has a 52 week low of $58.89 and a 52 week high of $89.83.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.10 by $0.11. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The business had revenue of $1.08 billion during the quarter, compared to analyst estimates of $1.05 billion. During the same quarter last year, the firm earned $0.96 earnings per share. The company’s revenue for the quarter was up 7.9% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. As a group, equities research analysts anticipate that The Cooper Companies, Inc. will post 4.63 EPS for the current year.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.